Prosecution Insights
Last updated: October 02, 2026

Examiner: DIETRICH, JOSEPH M

Tech Center 3700 • Art Units: 3762 3792 3796

This examiner grants 81% of resolved cases

Analysis

Joseph M. Dietrich has managed 938 resolved cases in Art Unit 3762, part of Tech Center 3700. The examiner has an allowance rate of 80.8% and a median days to allowance of 1112. The interview lift of 8.6% indicates that interviews provide a helpful boost to an already strong allowance rate. This profile suggests a consistent and generally favorable environment for applicants, albeit with a longer timeline.

Practitioners in Tech Center 3700 can expect a high probability of success, as the 80.8% allowance rate is quite robust across 938 cases. The 1112-day median to allowance is a key factor for planning, as it indicates a more extended prosecution process. The 8.6% interview lift is a useful tool for overcoming specific rejections and reaching the 80.8% baseline more efficiently. Given the large volume of resolutions, the data provides a reliable foundation for developing a strategy that balances the high success rate against the 1112-day median duration in Art Unit 3762.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Performance Statistics

80.8%
Allow Rate
+10.8% vs TC avg
980
Total Applications
+8.6%
Interview Lift
1112
Avg Prosecution Days
Based on 938 resolved cases, 2023–2026

Rejection Statute Breakdown

2.4%
§101 Eligibility
20.9%
§102 Novelty
48.8%
§103 Obviousness
13.1%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
19080381 Paresthesia-Free Spinal Cord Stimulation Occurring at Lower Frequencies and Sweet Spot Searching Using Paresthesia Non-Final OA Boston Scientific Neuromodulation Corporation
19042149 COMPUTER-ASSISTED PAIN MAPPING AND NEUROMODULATION SYSTEM Non-Final OA Boston Scientific Neuromodulation Corporation
18655695 MULTIFACTORIAL QUANTITATION OF NEUROSTIMULATION TREATMENTS FOR AUTONOMIC DISORDERS Non-Final OA Boston Scientific Neuromodulation Corporation
18641697 Optical Tracker And Surgical Device With An Optical Tracker Non-Final OA Stryker European Operations Limited
18457903 PASSIVE TEMPERATURE LOGGING FOR AN OBJECT Final Rejection Stryker Corporation
18926470 BED HAVING FEATURES FOR IMPROVING A SLEEPER'S BODY THERMOREGULATION DURING SLEEP Non-Final OA SNBR INC.
18852750 REPEATED INTERMITTENT ECG EVENT DETECTION Non-Final OA KONINKLIJKE PHILIPS N.V.
18890928 METHOD AND APPARATUS FOR DELIVERING AN OXYGENATED FLUID Non-Final OA ABIOMED, Inc.
18555407 PHOTOCHEMICAL TISSUE BONDING CLAMP AND IRRADIATION CHAMBER AND METHOD OF USE THEREOF Final Rejection The General Hospital Corporation
19027936 Automatic Lead Switching Non-Final OA Physio-Control, Inc.
18737286 ELECTRICAL FIELD USAGE IN COCHLEAS Non-Final OA Cochlear Limited
18257713 ELECTRICAL CONNECTOR WITH TORSION RESISTANCE Final Rejection Cochlear Limited
18493925 SYSTEMS AND METHODS FOR TREATING AND INHIBITING WOUND INFECTIONS Non-Final OA Board of Regents of the University of Nebraska
18698295 INTERMEDIATE STORAGE UNIT FOR CYCLICAL POWER SMOOTHING AND OPHTHALMOLOGICAL LASER THERAPY SYSTEM HAVING AN INTERMEDIATE STORAGE UNIT Non-Final OA Carl Zeiss Meditec AG
19077679 OPTIC ELEMENT FOR LASER TREATMENT OF A DERMATOLOGIC CONDITION Non-Final OA CarbonWave, Inc.
18201179 Device and Method for Detection of Post-Surgical Infection and Other Disease Non-Final OA University of Cincinnati
18686890 DEVELOPMENT OF A BEAT-TO-BEAT FETAL ELECTROCARDIOGRAM Final Rejection CHILDREN'S NATIONAL MEDICAL CENTER
18986129 SCALAR TRANSLOCATION DETECTION FOR AN ELECTRODE LEAD OF A COCHLEAR IMPLANT SYSTEM Non-Final OA Advanced Bionics AG
18174557 APPARATUS FOR DELIVERING CUSTOMIZED STIMULATION WAVEFORMS Final Rejection Nalu Medical, Inc.
18734980 Communication Methods and Architecture for Heart Treatment Systems Final Rejection TC1 LLC

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month